Delivery Order SPE2DB20D3103-SPE2DB23FP7U1

Award Date 9/19/23
Potential Completion Date 9/20/23
Potential Value $4.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Mucinex ER 600 mg tablets. The total ceiling value of the contract is $1,840.50, with a period of performance through April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
This federal contract award is for the delivery of Mucinex D ER 600-60 mg tablets to the Defense Logistics Agency (DLA). The $1,060.43 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company that is a subsidiary of Cencora, Inc. The award has an ultimate completion date of January 18, 2023 and was issued on January 17, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, valued at $4,550.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of medical products, including the prescription drug Mucinex D ER 600-60 mg Tablet 36s. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The $2,198.27 firm fixed-price delivery order is for the supply of Mucinex D ER 600-60 MG Tablets in quantities of 18s, with a performance period ending on January 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the supply of pharmaceutical and medical products to the U.S. government. The $1,513.08 firm-fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of Mucinex D ER 600-60 MG tablets. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,176.55 Firm Fixed Price Delivery Order contract is for the supply of MUCINEX D ER 600-60 MG TABLET 18S, a pharmaceutical product. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mucinex D ER 600-60 mg tablets. The $1,214.99 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,395.99 firm-fixed-price delivery order is for Mucinex D ER 600-60 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This single-award IDC serves as the primary vehicle for Cencora, Inc. to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award provides for the delivery of Mucinex ER 600 mg tablets to support military healthcare programs. The total ceiling value of this specific DO is $1,569.47, with a completion date of December 22, 2023. This contract was awarded on an open...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, over-the-counter medications, syringes, vials, and test kits, to support military...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP7U1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of Mucinex D ER 600-60 MG Tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The firm-fixed-price contract, valued at $4,708.42, has a completion date of September 20, 2023.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:05 AM